TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,810,776 | -48.8% | 216,600 | +52.0% | 2.08% | -55.6% |
| Q2 2023 | $3,539,700 | -30.7% | 142,500 | -58.0% | 4.68% | -19.0% |
| Q1 2023 | $5,106,080 | +313.4% | 339,500 | +225.2% | 5.77% | +390.5% |
| Q4 2022 | $1,235,052 | -38.4% | 104,400 | -69.2% | 1.18% | -43.8% |
| Q3 2022 | $2,006,000 | -35.0% | 338,800 | -53.3% | 2.09% | -39.5% |
| Q2 2022 | $3,086,000 | -69.0% | 726,200 | -30.7% | 3.46% | -62.3% |
| Q1 2022 | $9,966,000 | -0.5% | 1,047,900 | +98.8% | 9.16% | +17.2% |
| Q4 2021 | $10,013,000 | – | 527,000 | – | 7.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |